A remarkable new study shows stem cells can reverse MS in some patients
A majority of patients in a small trial who got stem cell transplants after chemo saw their quality of life…
Blood Stem Cell Transplant Better than DMTs at Reducing Risk of Disease Progression in RRMS
January 18, 2019 Autologous hematopoietic stem cell transplant is better than disease-modifying therapies (DMT) at reducing the risk of disease…
Stuart Schlossman
New stem cell research reveals what prevents remyelination
Dec 19, 2018 New research on remyelination could lead to a novel approach to developing treatments for multiple sclerosis. The…
Stuart Schlossman
What prevents remyelination? New stem cell research reveals a critical culprit
December 18, 2018, University at Buffalo Credit: CC0 Public Domain New research on remyelination, the spontaneous regeneration…
Stuart Schlossman
FDA Gives Green Light to Phase 2 Trial of NurOwn Stem Cell Therapy in Progressive MS Patients
December 19, 2018 The U.S. Food and Drug Administration (FDA) has approved BrainStorm Cell Therapeutics‘ request to open a Phase 2…
Stuart Schlossman
Stem Cell Therapies for MS
Before anybody wants to shoot this messenger, being me, I want you all to know that i just found this…
Stuart Schlossman
MS Patients: Be Cautious of Stem Cell Therapy, Circumvention Tourism
SEPTEMBER 6, 2018 BY LAURA KOLACZKOWSKI MS Patients: Be Cautious of Stem Cell Therapy, Circumvention Tourism Columnist Laura Kolaczkowski shares her…
Stuart Schlossman
Those with MS Are Cautioned About Unsafe Stem Cell Treatments
People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That’s not…
Stuart Schlossman
A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells
Source Geeta Shroff Department of Stem Cell Therapy, Nutech Mediworld, New Delhi, India Abstract: Multiple sclerosis (MS), a complex disorder of…
Stuart Schlossman
Blood Stem Cell Transplant Superior to DMDs in Highly Active RRMS, MIST Trial Shows
April 23, 2018 Autologous non-myeloablative hematopoietic stem cell transplant was found to be significantly better at reducing risks for disability…
Stuart Schlossman
